Sage Journals: Discover world-class research

Retricted access

Research article

First published 2004-02

Effects of Intravenous Amino Acid Administration with Y-90 DOTA-Phe1-Tyr3-Octreotide (SMT487[OctreoTher™]) Treatment

David Bushnell, Yusuf Menda, Thomas O'Dorisio [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2004-04

Radiolabeled RGD-DTPA-Tyr 3 -Octreotate for Receptor-Targeted Radionuclide Therapy

Bert Bernard, Astrid Capello, Martin van Hagen [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2008-02

Comparison of [ 177 Lu-DOTA 0,Tyr 3 ]-Octreotate and [ 177 Lu-DOTA 0,Tyr 3 ]-Octreotide for Receptor-Mediated Radiation Therapy of the Xenografted Human Midgut Carcinoid Tumor GOT1

Christina Swärd, Peter Bernhardt, Viktor Johanson [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2003-08

Assessment of Hepatic Toxicity from Treatment with 90 Y-SMT 487 (OctreoTher™) in Patients with Diffuse Somatostatin Receptor Positive Liver Metastases

David Bushnell, Yusuf Menda, Mark Madsen [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2003-10

Tyr 3 -Octreotide and Tyr 3 -Octreotate Radiolabeled with 177 Lu or 90 Y: Peptide Receptor Radionuclide Therapy Results In Vitro

Astrid Capello, Eric P. Krenning, Wout A.P. Breeman [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2003-08

Biodistribution and Dosimetry of 177 Lu-Labeled [DOTA 0,Tyr 3 ]Octreotate in Male Nude Mice with Human Small Cell Lung Cancer

Anneli Schmitt, Peter Bernhardt, Ola Nilsson [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2007-10

Effects of Treatment with 177 Lu-DOTA-Tyr 3 -Octreotate on Uptake of Subsequent Injection in Carcinoid-Bearing Nude Mice

Peter Bernhardt, Jenny Oddstig, Lars Kölby [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2002-10

Octreotide and Octreotate Derivatives Radiolabeled with Yttrium: Pharmacokinetics in Rats

M. Laznicek, A. Laznickova, H. R. Mäcke [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2015-08

NeuroEndocrine Tumor Therapy with Lutetium-177-octreotate and Everolimus (NETTLE): A Phase I Study

Phillip G. Claringbold, J. Harvey Turner

Cancer Biotherapy and Radiopharmaceuticals

Open access

Research article

First published 2014-9

Positron Emission Tomographic Imaging of Copper 64– and Gallium 68–Labeled Chelator Conjugates of the Somatostatin Agonist Tyr 3 -Octreotate

Jessie R. Nedrow, Alexander G. White, Jalpa Modi [...]

Molecular Imaging

Search results